In ER + BC tumors, across HSD3B1 genotypes in both pre- and postmenopausal tumors, there was minimal variation in the transcriptome, including in the expression of canonical hormone receptor genes (ESR1, ESR2, PGR) (Figure 4, and Supplementary Table S4). This evidence concerns the gene ESR1 and breast cancer.